Hunter syndrome: Difference between revisions

	Hunter syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hunter syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hunter syndrome On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hunter syndrome All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hunter syndrome
CDC on Hunter syndrome
Hunter syndrome in the news
Blogs on Hunter syndrome
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Hunter syndrome

Revision as of 18:24, 26 February 2013

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: Iduronate-2-sulfatase deficiency; MPS II; mucopolysaccharidosis II; iduronate sulphatase deficiency

@@ Line 12: / Line 12: @@
 ==[[Hunter syndrome pathophysiology|Pathophysiology]]==
-==[[Hunter syndrome genetics|Genetics]]==
 ==[[Hunter syndrome differential diagnosis|Differentiating Hunter syndrome from other Diseases]]==
@@ Line 20: / Line 18: @@
 ==[[Hunter syndrome risk factors|Risk Factors]]==
-==[[Hunter syndrome biochemistry|Biochemistry]]==
 ==[[Hunter syndrome natural history, complications and prognosis|Natural History, Complications and Prognosis]]==